APPENDIX 1

APPENDIX 1

Submissions and Additional Information received by the Committee

Submissions

1

Name Withheld

2

Think Pharmacy Oxley

3

Cabrini

4

The Wesley Pharmacy Group

5

Sunshine Coast Haematology and Oncology Clinic

6

The Society of Hospital Pharmacists of Australia

7

Northern Cancer Institute

8

Epworth HealthCare

9

Slade Pharmacy Services

10

Joondalup Hospital Pharmacy

11

Confidential

12

Department of Health and Human Services Tasmania

13

Pharmaceutical Society of Western Australia

14

CanSpeak

15

Sydney Adventist Hospital, Adventist HealthCare

16

Clinical Oncological Society of Australia and Cancer Pharmacists Group

17

Medical Oncology Group of Australia Inc. and Private Cancer Physicians of Australia

18

Cancer Voices Australia

19

Integrated Clinical Oncology Network (ICON)

20

Community Pharmacy Chemotherapy Services Group

21

Mr John Jackson

22

Consumers Health Forum of Australia

23

Ramsay Pharmacy Services

24

Australian Private Hospitals Assocation

25

The Pharmacy Guild of Australia

26

UnitingCare Health

27

Medicines Australia

28

Confidential

29

Capital Chemist

30

Name Withheld

31

APHS Pharmacy Group

32

Pharmaceutical Society of Australia Ltd

33

Catholic Health Australia

34

Confidential

35

Department of Health and Ageing

36

South Australian Government

37

Confidential

   
Additional Information

1

Tabled document from Society of Hospital Pharmacists of Australia, at Sydney public hearing 28 March 2013

2

Tabled document from Slade Pharmacy Services, at Sydney public hearing 28 March 2013

3

Tabled document from APHS Pharmacy Group, at Sydney public hearing 28 March 2013

4

Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013

5

Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013

6

Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013

7

Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013

8

Tabled document from Northern Cancer Institute, at Sydney public hearing 28 March 2013

9

Research paper presentation, from APHS Pharmacy Group, received 12 April 2013

10

Sustainable funding model, from Society of Hospital Pharmacists of Australia, received 11 April 2013

   
Correspondence

1

Correction from Society of Hospital Pharmacists of Australia to evidence given at Sydney public hearing 28 March 2013

2

Correspondence from SA Health, received 4 April 2013

   
Answers to Questions on Notice

1

Answers to Questions on Notice received from Northern Cancer Institute, 2 April 2013

2

Answers to Questions on Notice received from Clinical Oncological Society of Australia, 3 April 2013

3

Answers to Questions on Notice received from CanSpeak, 8 April 2013

4

Answers to Questions on Notice received from Sydney Adventist Hospital, 8 April 2013

Navigation: Previous Page | Contents | Next Page